Prevalence of urogenital inflammatory diseases associated with genital mycoplasms. Treatment efficacy | Zendy

О. В. Лысенко | Zendy; Т. В. Кузнеченкова | Zendy; В. А. Игликов | Zendy; V P DERYABINA | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevalence of urogenital inflammatory diseases associated with genital mycoplasms. Treatment efficacy

Author(s) -

О. В. Лысенко,

Т. В. Кузнеченкова,

В. А. Игликов,

V P DERYABINA

Publication year - 2010

Publication title -

vestnik dermatologii i venerologii

Language(s) - English

Resource type - Journals

eISSN - 2313-6294

pISSN - 0042-4609

DOI - 10.25208/vdv939

Subject(s) - josamycin , ureaplasma urealyticum , mycoplasma genitalium , ureaplasma , medicine , azithromycin , gynecology , genitourinary system , sex organ , mycoplasma hominis , doxycycline , chlamydia trachomatis , biology , antibiotics , mycoplasma , microbiology and biotechnology , genetics

Examination of 15765 women by PCR or culture method in the Southern Urals revealed genital mycoplasmas (M.hominis, M.genitalium, Ureaplasma spp.) in 25.8% of cases; they were more frequently met among socially non-adapted women (65,9% vs 17,2% in socially adapted group of women). Prescription of Josamycin (Wilprafen®), 500 mg TID for 10 days to women of both social groups provided the high level of antimicrobial effectiveness (92%) and favorable safety profile.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research